Bifogade filer
PDF
Kurs
-12,05%
Likviditet
0,10 MSEK
Kalender
| Est. tid* | ||
| 2026-02-19 | 08:40 | Bokslutskommuniké 2025 |
| 2025-11-28 | 08:10 | Kvartalsrapport 2025-Q3 |
| 2025-08-26 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-21 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2025-05-20 | - | Årsstämma |
| 2025-05-20 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-25 | - | Bokslutskommuniké 2024 |
| 2024-12-17 | - | Extra Bolagsstämma 2024 |
| 2024-11-19 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-27 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-22 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2024-05-21 | - | Årsstämma |
| 2024-05-21 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-20 | - | Bokslutskommuniké 2023 |
| 2023-11-10 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-22 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-24 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2023-05-23 | - | Årsstämma |
| 2023-05-23 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-15 | - | Bokslutskommuniké 2022 |
| 2022-11-16 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-23 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2022-05-10 | - | Årsstämma |
| 2022-05-10 | - | Kvartalsrapport 2022-Q1 |
| 2022-03-29 | - | Extra Bolagsstämma 2022 |
| 2022-02-22 | - | Bokslutskommuniké 2021 |
| 2021-11-11 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-13 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-20 | - | Split SYNT 1:10 |
| 2021-05-12 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2021-05-11 | - | Årsstämma |
| 2021-05-11 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-12 | - | Kvartalsrapport 2020-Q3 |
| 2020-10-02 | - | X-dag ordinarie utdelning SYNT 1.50 SEK |
| 2020-07-14 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-05 | - | Årsstämma |
| 2020-05-05 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-12 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-14 | - | Kvartalsrapport 2019-Q2 |
| 2019-04-30 | - | X-dag ordinarie utdelning SYNT 1.50 SEK |
| 2019-04-29 | - | Årsstämma |
| 2019-04-29 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-27 | - | Bokslutskommuniké 2018 |
| 2018-11-16 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-04-26 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2018-04-25 | - | Årsstämma |
| 2018-04-25 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-21 | - | Bokslutskommuniké 2017 |
| 2017-11-10 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-26 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2017-04-25 | - | Årsstämma |
| 2017-04-25 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-15 | - | Bokslutskommuniké 2016 |
| 2016-10-28 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-26 | - | Kvartalsrapport 2016-Q2 |
| 2016-04-27 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2016-04-26 | - | Årsstämma |
| 2016-04-26 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-26 | - | Bokslutskommuniké 2015 |
| 2015-10-30 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-28 | - | Kvartalsrapport 2015-Q2 |
| 2015-04-13 | - | Årsstämma |
| 2015-04-13 | - | Kvartalsrapport 2015-Q1 |
| 2015-02-17 | - | X-dag ordinarie utdelning SYNT 0.00 SEK |
| 2015-02-13 | - | Bokslutskommuniké 2014 |
| 2014-11-28 | - | Kvartalsrapport 2014-Q3 |
| 2014-09-26 | - | Extra Bolagsstämma 2014 |
| 2014-08-29 | - | Kvartalsrapport 2014-Q2 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
The Board of Directors of SyntheticMR AB (publ) has decided to postpone the publication of the interim report for the third quarter to November 28, 2025. The previously communicated publication date was November 26, 2025. The reason for the postponement is that the report is not yet finalized, as CEO Lena Åredal has been on an important business trip.
For more information please contact:
Lena Åredal, VD
Telefon: +46 (0)76-770 99 08
E-post: lena.aredal@syntheticmr.com
SyntheticMR AB (publ) develops and markets innovative imaging solutions that enhance neuroimaging workflow efficiency and diagnostic precision. SyntheticMR's SyMRI® solution measures brain absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single fast scan. Combinostics, a SyntheticMR company, offers the AI-powered cNeuro® suite of products that help clinicians make a difference in the lives of patients with neurological disorders. Our products are, among other things, CE-marked and FDA-approved, and we are listed on Spotlight Stock Market Exchange in Stockholm. SyntheticMR is headquartered in Linköping, Sweden, with an additional office in Tampere, Finland. For more information, please visit syntheticmr.com and combinostics.com.